HeartMeds,
Evolocumab reduces LDL and CV Events. We've heard this before. Next blockbuster? Evolocumab reduces LDL and CV Events. We've…
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Overview of attention for article published in New England Journal of Medicine, March 2015
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (92nd percentile)
Mentioned by
- news
- 26 news outlets
- blogs
- 8 blogs
- policy
- 3 policy sources
- 63 X users
- patent
- 10 patents
- 10 Facebook pages
- wikipedia
- 1 Wikipedia page
- googleplus
- 1 Google+ user
- 5 Redditors
- f1000
- 1 research highlight platform
- guideline
- 17 clinical guideline sources
Readers on
- mendeley
- 973 Mendeley